These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 2825102
1. Tumor cell type versus staging in the prognosis of carcinoma of the lung. Greenberg SD, Fraire AE, Kinner BM, Johnson EH. Pathol Annu; 1987; 22 Pt 2():387-405. PubMed ID: 2825102 [Abstract] [Full Text] [Related]
2. [The postoperative survival in pulmonary carcinomas depending on the histological type and stage]. Campobasso O, Andrion A, Mancuso M, De Simone M, Ribotta M. Ann Osp Maria Vittoria Torino; 1987; 31():9-24. PubMed ID: 2562416 [Abstract] [Full Text] [Related]
3. Prognosis and survival in resected lung carcinoma based on the new international staging system. Naruke T, Goya T, Tsuchiya R, Suemasu K. J Thorac Cardiovasc Surg; 1988 Sep; 96(3):440-7. PubMed ID: 2842549 [Abstract] [Full Text] [Related]
4. Prognostic indicators for survival in stage I carcinoma of the lung: a histologic study of 47 surgically resected cases. Elson CE, Roggli VL, Vollmer RT, Greenberg SD, Fraire AE, Spjut HJ, Yesner R. Mod Pathol; 1988 Jul; 1(4):288-91. PubMed ID: 2853362 [Abstract] [Full Text] [Related]
5. Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage. Juczewska M, Chyczewski L, Telego M, Chyczewska E, Nikliński J, Tańska M, Laudański J. Rocz Akad Med Bialymst; 1997 Jul; 42 Suppl 1():254-70. PubMed ID: 9337543 [Abstract] [Full Text] [Related]
6. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis]. Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y. Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638 [Abstract] [Full Text] [Related]
7. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up. Higashiyama M, Oda K, Okami J, Maeda J, Kodama K, Takenaka A, Nakayama T, Yoneda G. Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255 [Abstract] [Full Text] [Related]
8. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma. Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N. Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038 [Abstract] [Full Text] [Related]
9. [Results of surgical treatment of stage I lung cancer]. Shimizu J, Watanabe Y, Oda M, Hayashi Y, Ota Y, Morita K, Arano Y. Nihon Geka Gakkai Zasshi; 1993 May; 94(5):505-10. PubMed ID: 8392659 [Abstract] [Full Text] [Related]
10. [The relationship of histological type and tumor location to prognosis in 1000 patients with lung resection with special reference to adenocarcinoma]. Wilde J, Haenselt V, Luft D, Luft P, Welker L. Pneumologie; 1990 Dec; 44(12):1287-93. PubMed ID: 2178263 [Abstract] [Full Text] [Related]
11. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases. Castro CY, Stephenson M, Gondo MM, Medeiros LJ, Cagle PT. Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942 [Abstract] [Full Text] [Related]
12. TNM stage is the most important determinant of survival in metachronous lung cancer. Lee BE, Port JL, Stiles BM, Saunders J, Paul S, Lee PC, Altorki N. Ann Thorac Surg; 2009 Oct; 88(4):1100-5. PubMed ID: 19766788 [Abstract] [Full Text] [Related]
13. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension. Okada M, Sakamoto T, Nishio W, Uchino K, Tsubota N. Cancer; 2003 Aug 01; 98(3):535-41. PubMed ID: 12879471 [Abstract] [Full Text] [Related]
14. Expression of MDA-7/IL-24 and its clinical significance in resected non-small cell lung cancer. Ishikawa S, Nakagawa T, Miyahara R, Kawano Y, Takenaka K, Yanagihara K, Otake Y, Katakura H, Wada H, Tanaka F. Clin Cancer Res; 2005 Feb 01; 11(3):1198-202. PubMed ID: 15709189 [Abstract] [Full Text] [Related]
15. [Survival rate following operation for bronchial cancer--relation to tumor stage and histology]. Eckersberger F, Moritz E, Dorda W, Schlick W, Wolner E. Prax Klin Pneumol; 1988 Jul 01; 42(7):583-4. PubMed ID: 2847135 [No Abstract] [Full Text] [Related]
16. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A, Shirakusa T, Miyoshi T, Hamada T, Enatsu S, Maekawa S, Hiratsuka M. Thorac Cardiovasc Surg; 2006 Feb 01; 54(1):42-6. PubMed ID: 16485188 [Abstract] [Full Text] [Related]
17. [Pathological variability and cancer treatment in lung cancer]. Kodama T. Gan To Kagaku Ryoho; 1986 Sep 01; 13(9):2708-17. PubMed ID: 3019250 [Abstract] [Full Text] [Related]
18. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent. Gouyer V, Conti M, Devos P, Zerimech F, Copin MC, Créme E, Wurtz A, Porte H, Huet G. Cancer; 2005 Apr 15; 103(8):1676-84. PubMed ID: 15754326 [Abstract] [Full Text] [Related]
19. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C. Ann Thorac Surg; 2006 Jun 15; 81(6):1988-95. PubMed ID: 16731118 [Abstract] [Full Text] [Related]
20. The prognostic impact of tumor size in resected stage I non-small cell lung cancer: evidence for a two thresholds tumor diameters classification. Christian C, Erica S, Morandi U. Lung Cancer; 2006 Nov 15; 54(2):185-91. PubMed ID: 16996167 [Abstract] [Full Text] [Related] Page: [Next] [New Search]